Cole Robinson, MD
Interventional Pain Medicine · Richfield, UTNPI 1871799528
Payments from drug & device makers
What this record shows
Boston Scientific accounts for 96.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $2,287 and has fallen 87.0% since, to $298 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in UT, where the typical reported total is $7,299.
Across 129 payments — averaging $41.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Relievant Medsystems, Inc.$64
- Nevro Corp.$45
- Stryker$34
- Pfizer$16
- Abbott$15
What the payments were for
- Travel & lodging$3,14958%
- Food & beverage$2,25042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 119 | $5,224 |
| Relievant Medsystems, Inc. | 4 | $64 |
| Nevro Corp. | 3 | $45 |
| Stryker | 1 | $34 |
| Pfizer | 1 | $16 |
| Abbott | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$1,432
How this compares
$5,399 in reported general payments places this provider in the 35th percentile of 26 interventional pain medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 131 | $12,861 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 232 | $6,138 |
| Buprenorphine | 14 | $3,774 |
| Gabapentin | 239 | $3,752 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 167 | $3,340 |
| Fentanyl | 18 | $1,818 |
| Morphine Sulfate ErMorphine Sulfate | 58 | $1,281 |
| Pregabalin | 74 | $1,170 |
| Celecoxib | 49 | $904 |
| Tramadol Hcl | 79 | $647 |
| Baclofen | 52 | $510 |
| Morphine Sulfate | 18 | $416 |
| Duloxetine Hcl | 18 | $416 |
| Ibuprofen | 27 | $357 |
| Buprenorphine Hcl | 20 | $311 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Richfield
- Bryan HoelzerVineyard$718K
- Nathan ClementsSaint George$29K
- Rick ObraySt George$23K
- Brian RichardsonLogan$19K
- Alex NelsonMurray$17K
- Steven LarsenSaint George$14K
- J Riley StringhamProvo$13K
- Craig DavisWest Jordan$13K
- Geeta NagpalWest Jordan$11K
- Ashleigh ByrneWest Jordan$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.